| dc.description.abstract | Dans ce numéro, les articles suivants sont analysés :1. Cai Y, Fang L, Yang J, Zhou X, Liu L, Li A, et al. Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease. JAMA Neurol. 2025;82(8):848-58. 2. Chou YC, Han ML, Chiu THT, Lee MS, Chiou JM, Chen JH, et al. Longitudinal Association of Inflammatory Diets on Cognition in Older Adults: Insights from the Oral-Gut-Brain Axis. J Am Geriatr Soc. 2025;73(9):2747-56. 3. Ma'u E, Cullum S, Rohr S, Brayne EC. Are modifiable risk factors for dementia really modifiable? Curr Opin Psychiatry. 2025;38(5):348-54. 4. Mila-Aloma M, Tosun D, Schindler SE, Hausle I, Petersen KK, Li Y, et al. Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks. Ann Neurol. 2025;98(3):508-23. 5. Mitchell JJ, Hamer M, James SN, Norris T, Jefferis BJ, Wannamethee SG, et al. Bidirectional associations of Physical Activity and Cognitive Function in Midlife Adults: A Longitudinal Analysis across 26 years follow-up. Am J Epidemiol. 2025. 6. Paczynski M, Hofmann A, Posey Z, Gregersen M, Rudman M, Ellington D, et al. Lecanemab Treatment in a Specialty Memory Clinic. JAMA Neurol. 2025;82(7):655-65. 7. Pichet Binette A, Smith R, Salvado G, Tideman P, Glans I, van Westen D, et al. Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease. JAMA Neurol. 2025;82(7):666-75. 8. Piura YD, Satyadev N, Corriveau-Lecavalier N, Kuchenbecker LA, Haydu LE, Geschwind MD, et al. Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia. Ann Neurol. 2025;98(4):764-76. 9. Qian Y, Pomeroy ML, Petchler CM, Abshire Saylor M, Cudjoe TKM, Ornstein KA. The Epidemiology of Social Isolation and Loneliness Among Family and Unpaid Caregivers of Older Adults: Findings From the National Study of Caregiving. J Gerontol B Psychol Sci Soc Sci. 2025;80(7). 10. Skillback TB, Jonsson L, Skoog I, Blennow K, Eriksdotter M, Zetterberg H, et al. Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia. JAMA Neurol. 2025;82(6):580-8. 11. Smith JR, Pike JR, Gottesman RF, Knopman DS, Lutsey PL, Palta P, et al. Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia. JAMA Neurol. 2025;82(7):644-54. 12. Walsemann KM, Jackson HM, Boardman JD, Herd P. APOE genotype and cognitive decline: educational context as a moderator of genetic risk. J Gerontol B Psychol Sci Soc Sci. 2025;80(8). | |
